share_log

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $10

Benzinga ·  Aug 10 00:17  · Ratings

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price target from $14 to $10.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment